Zenith was established in the year of 2000 by our founder Late Shri Ramniklal Soni as an organization which has been built brick by brick on the foundation of care and giving our best to “CONTRIBUTE FOR HEALTH AND WELLBEING” for human life. This is growing strong with a clear vision and mission to provide the best quality product at a cost effective price. A WHO-GMP compliant manufacturing unit and Quality management system is ISO 9001:2015 certified (Euro-UK Certification body). We are specialized in manufacturing high quality and affordable Medicines to support our patients in need. Zenith offers a wide range of formulations in various forms such as ORS Powder, Liquid Oral, Ointments, Creams, Gels and Liquid Externals, Capsules, Tablets. Zenith is enjoying respectable market share through his 100% owned subsidiaries Biozen Healthcare and Biogenesis Corporation in India.
Zenith Drugs IPO Date, Price & Offer Details
The following table provides all the information related to Zenith Drugs IPO including the date, price and offer details of Zenith Drugs IPO.
Zenith Drugs IPO Date, Price & Offer Details
|
|
|---|---|
| Issue Open | 19-02-2024 |
| Issue Close | 22-02-2024 |
| Allotment Date | 23-02-2024 |
| Unblocked Amount | 26-02-2024 |
| Credit Demat Amount | 26-02-2024 |
| Listing Date | 27-02-2024 |
| Issue Size |
51,48,800 Total Equity Share
|
| Issue Size | ₹ 40.68 Cr |
| IPO Price Band | ₹ 75 - 79 Per Equity Share |
| Minimum Share Bid | 1600 |
| Minimum Investment Amount [₹] | ₹ 1,26,400 |
| Face Value | ₹ 10 Per Equity Share |
| Qualified Institutional Buyer [QIB] | 50 % |
| High Networth Individual [HNI] | 15 % |
| Retail Individual Investor [RII] | 35 % |
| Listing On | NSE SME |
| Review / Ex My View** | Neutral |
Zenith Drugs IPO Expected Premium (GMP)** (Read Disclaimer)
www.liveipo.in or producer will not be responsible for any kind of your profit and losses. So applying to any IPO at your own risk. We do not buy or sell any type of IPO Application related to IPO Gray Market Premium. We only share IPO information. We are Not a Financial Advisor. Please consult your financial advisor before investing or trading. Stock Market investments are subject to market risk.
Zenith Drugs IPO Expected Grey Market Premium
|
||||||
|---|---|---|---|---|---|---|
| IPO Name | Offer Price | Ex-Premium | Kostak | S2S | Review | |
| Zenith Drugs IPO | 79 | 10 | - | - | Neutral | |
Zenith Drugs Company Financial Report (₹ in Cr)
As per we are checking Zenith Drugs company financials report and we are displaying report data as shown in below table.
Zenith Drugs Company Financial Details (₹ in Cr)
|
||||
|---|---|---|---|---|
| Financial Year | Total Asset | Total Revenue | Total Expenses | Profit After Tax |
| FY-2021 | - | 73.52 | 68.92 | 3.03 |
| FY-2022 | 68.58 | 92.67 | 88.26 | 3.13 |
| FY-2023 | 97.93 | 115.70 | 108.49 | 5.15 |
| 30-09-2023 | 112.49 | 69.48 | 61.87 | 5.39 |
Zenith Drugs Company Valuation Details
As per we check Zenith Drugs company financials report and we display company valuation report data as shown in below table
Zenith Drugs Company Valuation Details
|
|
|---|---|
| Earnings Per Share [EPS] | ₹ 4.29 |
| Price/Earnings [P/E] Ratio | 12.56 |
| Return on Net Worth [RoNW] | 29.88 % |
| Net Asset Value [NAV] | ₹ - Per Share |
Zenith Drugs IPO Share Lot Size
The following table provides all the information related to Zenith Drugs IPO Lot size, share and investment amount in Zenith Drugs IPO.
| Zenith Drugs IPO Share Lot Size | |||
|---|---|---|---|
| Application | Lot Size | Shares | Total Amount |
| Retail Min | 1 | 1600 | ₹1,26,400 |
| Retail Max | 1 | 1600 | ₹1,26,400 |
| Small HNI | 2 | 3200 | ₹2,52,800 |
Zenith Drugs IPO Related Link
|
|---|
| Zenith Drugs IPO GMP Zenith Drugs IPO Subscription Zenith Drugs IPO Allotment Status |
Zenith Drugs IPO Subscription Details
The following table provides all the information related to Zenith Drugs IPO issued total shares through this IPO, a total shares have been reserved for market movers for subscriptions as per the prospect report,
Zenith Drugs IPO Subscription Details
| ||||
|---|---|---|---|---|
| As on Date | QIB | NII | RII | Total |
| Shared Offered | 8,59,200 | 6,44,800 | 15,04,000 | 30,08,000 |
| Day-1 [19-02-24] |
0 [0] |
6,14,400 [0.95] |
49,32,800 [3.28] |
55,47,200 [1.84] |
| Day-2 [20-02-2024] |
30,30,400 [3.35] |
24,44,800 [3.79] |
1,38,60,800 [9.22] |
1,93,36,000 [6.43] |
| Day-3 [21-02-2024] |
30,40,000 [3.54] |
59,61,600 [9.25] |
2,85,58,400 [18.99] |
3,75,60,000 [12.49] |
| Day-4 [22-02-2024] |
9,16,97,600 [106.72] |
23,85,39,200 [369.94] |
20,84,04,800 [138.57] |
53,86,41,600 [179.07] |
Zenith Drugs IPO Listing Details
The following table provides all the information related to Zenith Drugs IPO Listing Details.
Zenith Drugs IPO Listing Details
| |
|---|---|
| Listing Date | 27-02-2024 |
| BSE Code | - |
| NSE Code | ZENITHDRUG |
| ISIN Code | INE0QWN01013 |
| IPO Price | ₹ 79 |
| Lot Size | 1600 |
| Expected Listing Price | ₹ 105 - ₹ 115 |
| Book Profit | ₹ 135 |
| Stop Loss | ₹ 95 |
| Listing Group | - |
| - | - |
Zenith Drugs IPO GMP, Grey Market Premium
In the below table we are providing the latest rate of Zenith Drugs IPO GMP, Kostak Rate, Subject to Sauda, Listing Gain and Rating of this Zenith Drugs IPO.
Zenith Drugs IPO Grey Market Premium
|
|---|
| Zenith Drugs IPO Grey Market Premium |
Zenith Drugs IPO Allotment Status
Zenith Drugs IPO Allotment will be available on below link so click on below link and check your Zenith Drugs IPO Allotment Status.
Zenith Drugs IPO Allotment Status
|
|---|
| Zenith Drugs IPO Allotment Status |
Zenith Drugs IPO Live Subscription
|
|---|
| Zenith Drugs IPO Subscription in NSE |
Zenith Drugs IPO Prospectus
|
|---|
| Zenith Drugs IPO DRHP
Zenith Drugs IPO RHP |
Zenith Drugs Company Contact Details
Zenith Drugs IPO Registrar
Zenith Drugs IPO Lead Managers
Disclaimer:-
- I request to all investors, before applying any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO.
- www.liveipo.in or producer will not be responsible for any kind of your profit and losses. So applying to any IPO at your own risk.
- We do not buy or sell any type of IPO Application related to IPO Gray Market Premium. We only share IPO information.
- Please do not subscribe to any IPO just by looking at the Gray Market Premium price. It can change at any time.
- We are Not a Financial Advisor. Please consult your financial advisor before investing or trading.
- All updates/posts/discussions are only for education and learning purpose.
- Disclaimer/Disclaimer/Terms and Conditions apply to all viewers and Members of this LiveIPO Groups or Channel.
- All contain or post is based on research and case studies gathered from different books, media, internet, space, etc
- LiveIPO group, Channel or Website does not or provide any tips/recommendations/ Investment advice etc.
- Group Admins or Owner are not responsible for any kind of your financial losses.
- We are not a published any kind of stock market magazines.
- We are not a SEBI registered analyst.
- Stock Market investments are subject to market risk🙏 Thanks
0 Response to "Zenith Drugs IPO"
Post a Comment